压缩治疗对中风患者上肢的影响:系统性审查协议
Jia Min Lee1, Siaw Chui Chai2, Dongdong Shi1
1Centre for Rehabilitation and Special Needs Studies, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
本系统性审查评估了对中风后上肢功能障碍的压缩疗法. 证据不一致,需要进行全面分析,以指导中风幸存者的康复策略.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 临床试验 临床试验
背景情况:
- 脑卒中是全球残疾的主要原因,经常导致上肢功能障碍.
- 压缩疗法越来越多地被探索为中风后上肢损伤的辅助治疗.
- 目前关于压缩疗法的有效性的证据是模两可的,强调需要进行系统审查.
研究的目的:
- 系统地评估压缩治疗在中风患者上肢功能障碍管理中的有效性.
- 综合现有的临床结果和压缩疗法对中风后上肢功能安全性的证据.
主要方法:
- 在多个数据库 (PubMed,Scopus等) 中进行全面的系统搜索. 和临床试验登记册.
- 独立的数据选,选择和提取由两个审查员进行,第三个审查员检查差异.
- 使用Cochrane RoB 2和RoBINS-I工具评估偏差风险,并通过GRADE方法确定证据.
主要成果:
- 数据将以叙述的方式进行综合,如果可能的话,将进行元分析.
- 结果包括上肢功能,活动,参与和安全 (不良影响) 的临床测量.
- 审查遵循系统审查和元分析 (PRISMA) 准则的首选报告项目.
结论:
- 这次审查将综合证据,以告知临床实践和对中风幸存者的压缩疗法的未来研究.
- 研究结果将澄清压缩疗法在中风后改善上肢功能方面的作用.
- 结果将通过同行评审的出版物进行传播.
更多相关视频
07:35Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
Published on: December 29, 2023
05:28Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
